Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β-Hydroxycholesterol and Changes in Midazolam Exposure

被引：9
作者：
Mangold, James B. [1 ]
Wu, Fan [1 ]
Rebello, Sam [1 ]
机构：
[1] Novartis Inst Biomed Res, Drug Metab & Pharmacokinet, E Hanover, NJ 07936 USA
来源：
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 2016年 / 5卷 / 04期
关键词：
ENDOGENOUS BIOMARKERS; CYTOCHROME-P450; 3A; INHIBITION; MARKER; METABOLISM; IMPACT;
D O I：
10.1002/cpdd.265
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：245 / 249
页数：5
相关论文
共 20 条
[1]   Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways [J].
Adams, M ;
Pieniaszek, HJ ;
Gammaitoni, AR ;
Ahdieh, H .
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (03) :337-345
[2]   A comparison of 4-hydroxycholesterol:cholesterol and 6-hydroxycortisol:cortisol as markers of CYP3A4 induction [J].
Arrhen, Yvonne Marde ;
Nylen, Hanna ;
Lovgren-Sandblom, Anita ;
Kanebratt, Kajsa P. ;
Wide, Katarina ;
Diczfalusy, Ulf .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (06) :1536-1540
[3]   Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin [J].
Bjorkhem-Bergman, Linda ;
Backstrom, Tobias ;
Nylen, Hanna ;
Ronquist-Nii, Yuko ;
Bredberg, Eva ;
Andersson, Tommy B. ;
Bertilsson, Leif ;
Diczfalusy, Ulf .
DRUG METABOLISM AND DISPOSITION, 2013, 41 (08) :1488-1493
[4]   Metabolism of 4β-hydroxycholesterol in Humans [J].
Bodin, K ;
Andersson, U ;
Rystedt, E ;
Ellis, E ;
Norlin, M ;
Pikuleva, I ;
Eggertsen, G ;
Björkhem, I ;
Diczfalusy, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :31534-31540
[5]   4β-Hydroxycholesterol is a new endogenous CYP3A marker:: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians [J].
Diczfalusy, Ulf ;
Miura, Jun ;
Roh, Hyung-Keun ;
Mirghani, Rajaa A. ;
Sayi, Jane ;
Larsson, Hanna ;
Bodin, Karl G. ;
Allqvist, Annika ;
Jande, Mary ;
Kim, Jong-Wook ;
Aklillu, Eleni ;
Gustafsson, Lars L. ;
Bertilsson, Leif .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (03) :201-208
[6]   4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans [J].
Diczfalusy, Ulf ;
Nylen, Hanna ;
Elander, Pontus ;
Bertilsson, Leif .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) :183-189
[7]   4β-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin [J].
Diczfalusy, Ulf ;
Kanebratt, Kajsa P. ;
Bredberg, Eva ;
Andersson, Tommy B. ;
Bottiger, Ylva ;
Bertilsson, Leif .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (01) :38-43
[8]   Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin [J].
Dutreix, Catherine ;
Lorenzo, Sebastien ;
Wang, Yanfeng .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (08) :915-920
[9]  
Jiang X, CLIN PHARM IN PRESS
[10]   CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4β-hydroxycholesterol levels [J].
Josephson, F. ;
Bertilsson, L. ;
Bottiger, Y. ;
Flamholc, L. ;
Gisslen, M. ;
Ormaasen, V. ;
Sonnerborg, A. ;
Diczfalusy, U. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (08) :775-781
12